Comparison of renal function and cardiovascular risk following acute myocardial infarction in patients with and without diabetes mellitus

被引:19
|
作者
Anavekar, Nagesh S. [1 ]
Solomon, Scott D. [2 ]
McMurray, John J. V. [3 ]
Maggioni, Aldo [4 ]
Rouleau, Jean Lucien [5 ]
Califf, Robert [6 ]
White, Harvey [7 ]
Kober, Lars [8 ]
Velazquez, Eric [6 ]
Pfeffer, Marc A. [2 ]
机构
[1] Univ Melbourne, Clin Trials Unit, Melbourne, Vic, Australia
[2] Brigham & Womens Hosp, Div Cardiovasc, Boston, MA 02115 USA
[3] Univ Glasgow, Western Infirm, Dept Cardiol, Glasgow G11 6NT, Lanark, Scotland
[4] Assoc Nazl Med Cardiol Ospedal Res Ctr, Florence, Italy
[5] Montreal Heart Inst, Montreal, PQ H1T 1C8, Canada
[6] Duke Univ, Med Ctr, Durham, NC USA
[7] Green Lane Hosp, Dept Cardiol, Auckland 3, New Zealand
[8] Rigshosp, Dept Cardiol, DK-2100 Copenhagen, Denmark
来源
AMERICAN JOURNAL OF CARDIOLOGY | 2008年 / 101卷 / 07期
关键词
D O I
10.1016/j.amjcard.2007.11.037
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Renal dysfunction is an independent risk factor for cardiovascular (cv) disease and its associated complications. diabetes mellitus (dm) is a common cause,of renal dysfunction. whether the presence or absence of din modifies the relation between renal dysfunction and cv disease is unclear. the valiant trial identified 14,527 patients with acute myocardial infarction complicated by either clinical or radiologic signs of heart failure and/or left ventricular dysfunction for whom baseline creatinine was measured. patients were randomly assigned to receive captopril, valsartan, or both. glomerular filtration rate (gfr) was estimated using the 4-component modification of diet in renal disease equation. using multivariable cox proportional modeling, the relation of overall mortality and composite cardiovascular events with estimated gfr (egfr) between patients with and without din was compared. mean egfrs were 66.8 +/- 22.0 and 71.2 +/- 21.0 ml/min/1.73 m(2) for patients with (n = 3,358) and without din (n = 11,169), respectively. the likelihood of experiencing death or the composite end point was higher in patients with than without dm for each level of renal function. the augmentation in risk of cv events based on reduced renal function was similar between groups. each decrease in egfr by 10 units was associated with hazards of 1.09 (95% confidence interval 1.06 to 1.12, p < 0.001) in patients with din and 1, 08 (95% confidence interval 1.06 to 1.10, p < 0.001) in patients without dm for risk of fatal and nonfatal cv outcomes independent of treatment assignment. in conclusion, although dm is associated with higher risk of renal dysfunction and adverse cv outcomes, patients without dm had a relation between renal function and cv risk similar to that for patients with dm after high-risk acute myocardial infarction. (C) 2008 Elsevier Inc.
引用
收藏
页码:925 / 929
页数:5
相关论文
共 50 条
  • [1] Diabetes, renal function, and cardiovascular risk following myocardial infarction: Lessons from the VALsartan in acute myocardial iNfarcTion trial (VALIANT)
    Anavekar, NS
    Solomon, SD
    Maggioni, AP
    Belenkov, Y
    Rouleau, JL
    McMurray, JJV
    Velazquez, EJ
    Califf, RM
    Pfeffer, MA
    [J]. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2006, 47 (04) : 217A - 217A
  • [2] Hospital outcome of acute myocardial infarction in patients with and without diabetes mellitus
    Otter, W
    Kleybrink, S
    Doering, W
    Standl, E
    Schnell, O
    [J]. DIABETIC MEDICINE, 2004, 21 (02) : 183 - 187
  • [3] Serum resistin in acute myocardial infarction patients with and without diabetes mellitus
    Ibrahim, Hesham H.
    Korah, Tarek E.
    Badr, Eman A. E.
    Elshafie, Maathir K.
    [J]. EGYPTIAN HEART JOURNAL, 2012, 64 (01): : 27 - 33
  • [4] Serum resistin in acute myocardial infarction patients with and without diabetes mellitus
    Korah, Tarek E.
    Ibrahim, Hesham H.
    Badr, Eman A. E.
    ElShafie, Maathir K.
    [J]. POSTGRADUATE MEDICAL JOURNAL, 2011, 87 (1029) : 463 - 467
  • [5] Comparison of Blood Glucose Values on Admission for Acute Myocardial Infarction in Patients With Versus Without Diabetes Mellitus
    Ishihara, Masaharu
    Kojima, Sunao
    Sakamoto, Tomohiro
    Kimura, Kazuo
    Kosuge, Masami
    Asada, Yujiro
    Tei, Chuwa
    Miyazaki, Shunichi
    Sonoda, Masahiro
    Tsuchihashi, Kazufumi
    Yamagishi, Masakazu
    Shirai, Mutsunori
    Hiraoka, Hisatoyo
    Honda, Takashi
    Ogata, Yasuhiro
    Ogawa, Hisao
    [J]. AMERICAN JOURNAL OF CARDIOLOGY, 2009, 104 (06): : 769 - 774
  • [6] Association of Clopidogrel Treatment With Risk of Mortality and Cardiovascular Events Following Myocardial Infarction in Patients With and Without Diabetes
    Andersson, Charlotte
    Lyngbaek, Stig
    Cu Dinh Nguyen
    Nielsen, Mia
    Gislason, Gunnar H.
    Kober, Lars
    Torp-Pedersen, Christian
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2012, 308 (09): : 882 - 889
  • [7] Diabetes mellitus as a contributor to the risk of acute myocardial infarction
    Tavani, A
    Bertuzzi, M
    Gallus, S
    Negri, E
    La Vecchia, C
    [J]. JOURNAL OF CLINICAL EPIDEMIOLOGY, 2002, 55 (11) : 1082 - 1087
  • [8] Patients with acute cerebral infarction and diabetes mellitus versus patients with acute cerebral infarction without diabetes mellitus
    Nacu, A.
    Thomassen, L.
    Fromm, A.
    Waje-Andreassen, U.
    Naess, H.
    [J]. JOURNAL OF NEUROLOGY, 2013, 260 : S81 - S81
  • [9] The incidence of mechanical and electric complications after acute myocardial infarction in patients with diabetes mellitus and in patients without diabetes mellitus
    Vodopic, Sanja
    Pantovic, S.
    Bozovic, S.
    [J]. EUROPEAN JOURNAL OF MEDICAL RESEARCH, 2011, 16 : 106 - 107
  • [10] Titration to High-Intensity Statin Therapy Following Acute Myocardial Infarction in Patients With and Without Diabetes Mellitus
    Gennaro Giustino
    Lisandro D. Colantonio
    Todd M. Brown
    April P. Carson
    Yuling Dai
    Michael E. Farkouh
    Keri L. Monda
    Paul Muntner
    Robert S. Rosenson
    [J]. Cardiovascular Drugs and Therapy, 2018, 32 : 453 - 461